A More Uniform Measurement of Factor VIII InhibitorsCarol K. Kasper, N. R. Shulman, David L. Aronson et al.|Thrombosis and Haemostasis|1975Cited by 587
A More Uniform Measurement of Factor VIII InhibitorsCarol K. Kasper, Jan van Eys, Louis M. Aledort et al.|Thrombosis and Haemostasis|1975Cited by 320
Human Recombinant DNA–Derived Antihemophilic Factor (Factor VIII) in the Treatment of Hemophilia ARichard S. Schwartz, Randy Allred, Charles F. Abildgaard et al.|New England Journal of Medicine|1990Cited by 266
Frequency of inhibitor development in haemophiliacs treated with low-purity factor VIIIJoseph E. Addiego, Louis M. Aledort, Carol K. Kasper et al.|The Lancet|1993Cited by 166
Hepatitis A Virus Transmission by Blood Products in the United StatesJames W. Mosley, Marek Nowicki, Carol K. Kasper et al.|Vox Sanguinis|1994Cited by 19